IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
24.63
-0.30 (-1.20%)
At close: Sep 12, 2025, 4:00 PM EDT
24.54
-0.09 (-0.35%)
After-hours: Sep 12, 2025, 5:45 PM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.16 billion as of September 12, 2025. Its market cap has decreased by -35.85% in one year.
Market Cap
2.16B
Enterprise Value
1.19B
1-Year Change
-35.85%
Ranking
Category
Stock Price
$24.63
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.16B, an increase of 900.58%. That is a compound annual growth rate of 44.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 2.18B | -1.64% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | 406.77M | 168.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 676.25B |
| Johnson & Johnson | 430.56B |
| AbbVie | 388.91B |
| UnitedHealth Group | 327.85B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 233.94B |